Trial Profile
Evaluate histological, virological, serological and biochemical response rates in chronic hepatitis B (CHB) patients receiving tenofovir or entecavir therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2018
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 04 May 2018 New trial record
- 24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases